CLINICAL_TRIALS
trial_result
· 2018-08-01
Clinical Trial Update: Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Venous Leg Ulcers [Phase 1]
Summary
Phase 1 safety study evaluating systemic exposure of Granexin Gel after topical application to venous leg ulcers.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Xequel Bio, Inc. | Conditions: Venous Leg Ulcer | Phase 1 | Status: COMPLETED